Eightco Holdings Inc. (ORBS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Eightco Holdings Inc. for the event date of December 29, 2025. The Company, incorporated in Delaware and trading on The Nasdaq Stock Market under the symbol "ORBS," is an emerging growth company. The filing primarily addresses the grant of Restricted Stock Units (RSUs) to executive officers, directors, and non-executive employees.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on equity compensation events rather than financial performance metrics.
Material Changes and Events
On December 29, 2025, the Company granted fully vested RSUs pursuant to the Cryptyde, Inc. 2022 Long-Term Incentive Plan. These grants were approved by the Board of Directors to recognize efforts related to a private placement offering in September 2025 and the implementation of digital asset treasury operations.
- Kevin O'Donnell (CEO): Granted 475,000 RSUs.
- Brett Vroman (CFO): Granted 60,000 RSUs.
- Frank Jennings (Director): Granted 60,000 RSUs.
- Louis Foreman (Director): Granted 55,000 RSUs.
- Nicola Caiano (Director): Granted 50,000 RSUs.
All RSUs granted in this filing vested in full on the grant date.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the context of the compensation grants. The grants are tied to the Company's digital asset treasury operations and a prior private placement.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the Cryptyde, Inc. 2022 Long-Term Incentive Plan to assess remaining capacity for future grants.
- Confirm the fair market value of the stock on December 29, 2025, to calculate the total compensation expense recognized for these grants.
- Review the details of the September 2025 private placement offering referenced as the basis for these awards.
- Check subsequent filings for any dilution impact resulting from the immediate vesting of 700,000 RSUs to executives and directors.